The decision to store adipose stem cells is a proactive and visionary step towards securing one’s future health, irrespective of age.
StemInsureTM provides the opportunity to preserve your stem cells, ensuring access to your younger and healthier self when facing future inflammatory conditions.
Personalized Stem Cells has completed the first ever FDA-approved clinical trial of GMP lab manufactured adipose derived stem cells for patients with knee osteoarthritis.
PSC investors benefit from Section 1202 of the Internal Revenue Code which offers a significant tax incentive.
Aging is a universal part of life, but have you ever wondered why some people seem to age more gracefully than others? The answer lies hidden within our genes, and a fascinating field of science known as epigenetics is shedding light on this timeless mystery.
Growth factors have the potential to be a useful tool in regenerative medicine but more studies are needed to ensure their safe and effective use.
While exosome therapy is a burgeoning field, there are currently no FDA approved exosome treatments as more studies are needed to confirm the safety and efficacy of such products.
Expanded access is an FDA program that under certain conditions allows the use of an investigational new drug (IND) to treat a patient with a serious or life-threatening disease outside of a clinical trial.
The Right to Try Act provides a new channel for eligible patients to request access to investigational drugs outside of their ongoing clinical trial.
The Right to Try Act allows patients access to treatments that are in the FDA’s drug approval pipeline but not yet approved.